-
Je něco špatně v tomto záznamu ?
The association among cervical, anal, and oral HPV infections in high-risk and low-risk women
B. Sehnal, M. Zikan, M. Nipcova, L. Dusek, D. Cibula, J. Slama,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Grantová podpora
NV17-32030A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2019
PubMed Central
od 2019
Europe PubMed Central
od 2019
ROAD: Directory of Open Access Scholarly Resources
od 2019
- Publikační typ
- časopisecké články MeSH
Objective: The human papillomavirus (HPV) can cause premalignant and malignant tumors in the anogenital and oropharyngeal regions. The aim of this study was to describe the association in the prevalence of cervical, anal, and oral HPV infections in high-risk patients with biopsy-confirmed high-grade cervical lesion compared to low-risk women. Study Design: A total of 718 immunocompetent women were enrolled in the study. The high-risk (HR) group consisted of 473 patients with biopsy-confirmed high-grade cervical lesion while the low-risk (LR) group consisted of other 245 women. All participants completed an anonymous self-administered questionnaire and were subjected to cervical, anal, and oral HPV genotyping using the Linear array HPV test. Results: A total of 81.4% women were infected in the cervix, 43.3% in the anus, and 2.7% in the oral cavity in the HR group in comparison with only 26.9%, 24.5%, and 1.4% in the low-risk LR group, respectively. The cervical and anal HPV infections were much more frequent in the HR patients (p < 0.001); the difference in the oral HPV prevalence was not significant (p = 0.511) between groups. Concurrent cervical-anal infection was observed in 39.3% of HR women and in 8.3% of the LR patients (p < 0.001) and it significantly increased with the grade of cervical lesion (ptrend<0.001). The higher prevalence of concurrent cervical-oral, anal-oral, and cervical-anal-oral infections in HR women was statistically not significant according to the generally small oral HPV prevalence. Conclusions: All HPV infections occurred more often in HR than in LR women but not all results were statistically significant. The genotype HPV 16 was found in approximately half of all infections at all sites.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035688
- 003
- CZ-PrNML
- 005
- 20210126132843.0
- 007
- ta
- 008
- 191007s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.eurox.2019.100061 $2 doi
- 035 __
- $a (PubMed)31517298
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Sehnal, Borek $u First Faculty of Medicine, Charles University and Hospital Na Bulovce, Department of Gynaecology and Obstetrics, Budinova 2, Praha 8, 180 81, Prague, Czech Republic.
- 245 14
- $a The association among cervical, anal, and oral HPV infections in high-risk and low-risk women / $c B. Sehnal, M. Zikan, M. Nipcova, L. Dusek, D. Cibula, J. Slama,
- 520 9_
- $a Objective: The human papillomavirus (HPV) can cause premalignant and malignant tumors in the anogenital and oropharyngeal regions. The aim of this study was to describe the association in the prevalence of cervical, anal, and oral HPV infections in high-risk patients with biopsy-confirmed high-grade cervical lesion compared to low-risk women. Study Design: A total of 718 immunocompetent women were enrolled in the study. The high-risk (HR) group consisted of 473 patients with biopsy-confirmed high-grade cervical lesion while the low-risk (LR) group consisted of other 245 women. All participants completed an anonymous self-administered questionnaire and were subjected to cervical, anal, and oral HPV genotyping using the Linear array HPV test. Results: A total of 81.4% women were infected in the cervix, 43.3% in the anus, and 2.7% in the oral cavity in the HR group in comparison with only 26.9%, 24.5%, and 1.4% in the low-risk LR group, respectively. The cervical and anal HPV infections were much more frequent in the HR patients (p < 0.001); the difference in the oral HPV prevalence was not significant (p = 0.511) between groups. Concurrent cervical-anal infection was observed in 39.3% of HR women and in 8.3% of the LR patients (p < 0.001) and it significantly increased with the grade of cervical lesion (ptrend<0.001). The higher prevalence of concurrent cervical-oral, anal-oral, and cervical-anal-oral infections in HR women was statistically not significant according to the generally small oral HPV prevalence. Conclusions: All HPV infections occurred more often in HR than in LR women but not all results were statistically significant. The genotype HPV 16 was found in approximately half of all infections at all sites.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zikan, Michal $u First Faculty of Medicine, Charles University and Hospital Na Bulovce, Department of Gynaecology and Obstetrics, Budinova 2, Praha 8, 180 81, Prague, Czech Republic.
- 700 1_
- $a Nipcova, Monika $u First Faculty of Medicine, Charles University and Hospital Na Bulovce, Department of Gynaecology and Obstetrics, Budinova 2, Praha 8, 180 81, Prague, Czech Republic.
- 700 1_
- $a Dusek, Ladislav $u Institute of Biostatistics and Analyses, Masaryk University, Kamenice 3, 625 00, Brno, Czech Republic.
- 700 1_
- $a Cibula, David $u First Faculty of Medicine, Charles University and General University Hospital, Gynaecologic Oncology Centre, Apolinarska 18, Praha 2, 128 51, Prague, Czech Republic.
- 700 1_
- $a Slama, Jiri $u First Faculty of Medicine, Charles University and General University Hospital, Gynaecologic Oncology Centre, Apolinarska 18, Praha 2, 128 51, Prague, Czech Republic.
- 773 0_
- $w MED00200567 $t European journal of obstetrics & gynecology and reproductive biology: X $x 2590-1613 $g Roč. 4, č. - (2019), s. 100061
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31517298 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20210126132839 $b ABA008
- 999 __
- $a ind $b bmc $g 1452348 $s 1074238
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 4 $c - $d 100061 $e 20190619 $i 2590-1613 $m European journal of obstetrics & gynecology and reproductive biology: X $n Eur J Obstet Gynecol Reprod Biol X $x MED00200567
- GRA __
- $a NV17-32030A $p MZ0
- LZP __
- $a Pubmed-20191007